MedTrace Logo

Trilogy AB Acetabular Hip System Post Approval Study

NCT00715026 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2014-11-26

Study results available
· View outcomes & findings →

Summary

This is a post-approval study with prospective enrollment in the United States and a retrospective enrollment outside the United States to obtain functional, quality of life and radiographic data, which will facilitate assessment of the clinical performance of the Zimmer Trilogy AB Acetabular Hip System.

Conditions

  • Osteoarthritis
  • Avascular Necrosis
  • Congenital Hip Dysplasia
  • Traumatic Arthritis

Interventions

DEVICE

Trilogy AB Acetabular Hip Implant System

Total hip replacement with ceramic on ceramic treatment surfaces.

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Kevin Schrock, MD · Schrock Orthopedic Research

  • Gwo-Chin Lee, MD · University of Pennsylvania/Penn Presbyterian Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00715026 on ClinicalTrials.gov